Apmonia Therapeutics

Website

Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. The company focuses on creating drugs to treat glioblastoma, ovarian, colorectal, and ...

Healthcare
Reims, France
Founded 2019
15 employees
Website
Valuation
$26.8M
Market implied
Share Price
N/A
Total Raised
$12.1M
Last Round
N/A
Investors
+9 other investors
View all 9 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Apmonia Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required